Date |
Research Question / Title |
Unique ID |
Research Team |
April 4, 2020
|
What is the evidence for early implementation of field hospitals for COVID-19?
|
EOC040203 RR
|
EOC
|
April 27, 2020
|
What is the best evidence to guide the sequence or priority of re-opening each type of healthcare service and how have the closures impacted patients?
|
EOC042202 RR
|
EOC
|
April 30, 2020
|
How is "compassionate visit" defined and operationalized in the context of an infectious outbreak or pandemic?
|
LTC042402 RR
|
Long Term Care
|
May 7, 2020
|
What are best practices for engaging family care providers during a pandemic?
|
LTC042401 RR
|
Long Term Care
|
May 22, 2020
|
In similar jurisdictions experiencing the COVID-19 pandemic, what is the proportion of patients receiving non-invasive ventilation versus those receiving intermittent mandatory ventilation?
|
EOC052102 RR
|
EOC
|
June 2, 2020
|
What proportion of healthcare workers are rt-PCR positive and IgM or IgG positive? [Update]
|
LAB040802v3 RR
|
Laboratory
|
July 27, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001 RR
|
EOC
|
July 29, 2020
|
What are the existing policies for the re-deployment or deployment of healthcare workers whose regular work has been disrupted by COVID-19 in high-resource clinical settings?
|
EOC072701 RR
|
EOC
|
August 29, 2020
|
Is there evidence of risks for using infrared thermometers?
|
EOC082502 RR
|
EOC
|
September 8, 2020
|
What are the safety risks or disinfection concerns with the use of intubation boxes?
|
EOC090202 RR
|
EOC
|
September 29, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401 RR
|
EOC
|
November 25, 2020
|
Are probiotics effective for prevention or therapy of respiratory tract infections in all ages?
|
EOC111201 RR
|
EOC
|
January 13, 2021
|
What are the outcomes of ECMO and COVID, particularly in small centers?
|
EOC011101 RR
|
EOC
|
January 19, 2021
|
How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models?
|
PH011401 RR
|
Public Health
|
February 27, 2021
|
What is the final disposition of post-COVID patients who require chronic ventilation in the ICU?
|
CC011101 RR
|
Critical Care
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
April 6, 2021
|
How to deliver remote ICU care for COVID-19 patients to avoid/prevent transfer from smaller communities to tertiary care hospitals
|
CC210301 RR
|
Critical Care
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
June 10, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 RR
|
EOC
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|